CANADA LIFE ASSURANCE Co
InsurancePosition in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1046192
WINNIPEG, A2
Position in REGN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$60,950,479
+$2,891,962 QoQ
Shares Held
78,886
+4.9% QoQ
Ownership
0.075%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CANADA LIFE ASSURANCE Co holds $291,138,584 across 78 Biotechnology names. REGN ranks #2 (20.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
192,144 | $85,799,981 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
78,886 | $60,950,479 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
57,255 | $18,943,961 | |
| 4 | INCY |
Incyte Corp
|
111,609 | $10,504,639 | |
| 5 | INSM |
INSMED Inc
|
53,890 | $8,812,092 | |
| 6 | ARGX |
Argenx SE
|
11,567 | $8,446,801 | |
| 7 | MRNA |
Moderna, Inc.
|
148,181 | $7,527,594 | |
| 8 | EXEL |
Exelixis, Inc.
|
167,451 | $7,181,973 |
All Filings in REGN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $60,950,479 | 78,886 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $58,058,517 | 75,218 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $51,168,819 | 91,004 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $45,724,350 | 87,094 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $79,039,645 | 124,623 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $86,095,765 | 120,865 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $132,662,282 | 126,196 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $126,219,243 | 120,091 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $97,369,338 | 101,164 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $98,357,940 | 111,988 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $101,522,814 | 123,363 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $88,810,825 | 123,599 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $108,328,972 | 131,840 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $104,057,616 | 144,226 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $116,547,848 | 169,187 | Shares | Sole | 2022-11-01 | |
| 2022-03-31 | $120,321,702 | 172,277 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $109,830,168 | 173,914 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $95,275,302 | 157,433 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $85,333,182 | 152,779 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $83,712,660 | 176,930 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $91,381,222 | 189,152 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $83,067,992 | 148,394 | Shares | Defined | 2020-11-18 | |
| 2020-06-30 | $81,149,961 | 130,121 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $31,321,361 | 64,145 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||